Immunitybio
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $6,106 | $1,047 | $40 | $139 |
Gross Profit | 5,954 | 1,047 | -4,515 | -4,425 |
EBITDA | -41,066 | -91,159 | -92,088 | -196,764 |
EBIT | -45,505 | -95,565 | -96,643 | -201,328 |
Net Income | -85,729 | -134,564 | -134,109 | -233,392 |
Net Change In Cash | 6,106 | 1,047 | 40 | 139 |
Free Cash Flow | -101,555 | -101,071 | -108,243 | -123,226 |
Cash | 111,966 | 130,104 | 133,035 | 265,452 |
Basic Shares | 697,961 | 686,938 | 672,831 | 670,867 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $622 | $240 | $934 | $605 |
Gross Profit | -17,890 | -23,952 | 934 | -8,542 |
EBITDA | -436,182 | -335,511 | -315,380 | -187,934 |
EBIT | -454,694 | -359,703 | -334,502 | -197,081 |
Net Income | -583,196 | -417,320 | -349,848 | -224,187 |
Net Change In Cash | 622 | 240 | 934 | 605 |
Cost of Revenue | -76,599 | 146,138 | -4,067 | |
Free Cash Flow | -397,341 | -436,900 | -307,982 | -173,393 |
Cash | 265,452 | 104,641 | 181,101 | 34,915 |
Basic Shares | 508,635 | 399,900 | 389,234 | 383,179 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.12 |
2024-06-30 | -$0.20 |
2024-03-31 | -$0.20 |
2023-12-31 | -$0.35 |
